Strategic Growth Publicly traded on NASDAQ (KRMD) with recent leadership hires and executive appointments, signaling an active expansion mindset and opportunities to engage senior decision-makers on strategic product roadmap and commercial partnerships.

Clinical Validation Recent presentations at oncology and focused symposiums, along with real-world data demonstrations of FreedomEDGE in infusion clinics, provide talking points to align with hospital systems, clinical researchers, and formulary committees during sales conversations.

Platform Synergy Development of a platform infusion system in collaboration with SCHOTT Pharma suggests a potential for integrated solutions, enabling cross-sell opportunities to customers needing vial and prefilled syringe compatibility as well as end-to-end infusion workflows.

Home Care Focus Expertise in home and specialty infusion solutions positions KORU to target home infusion providers, long-term care networks, and patient-centric programs seeking safer, efficient, patient-friendly subcutaneous and syringe-based therapy delivery.

Technology & Scale Utilization of cloud, analytics, and enterprise tools (AWS, Salesforce, data tracking) indicates readiness for scalable deployments and customer success programs, enabling upsell of data-driven monitoring, workflow automation, and service contracts.